ArticleKidney research and clinical practice2024

The role of nafamostat mesylate anticoagulation in continuous kidney replacement therapy for critically ill patients with bleeding tendencies: a retrospective study on patient outcomes and safety.

Taeil Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.